12/19/2013Antibody Solutions Announces Partnership with OMT, Inc.
Antibody Solutions announced today that it had entered into a strategic partnership with Open Monoclonal Technology to use human antibody transgenic OmniRat and OmniMouse to generate diverse portfolios of human therapeutic antibodies. This technology offers significant advantages over 1st generation transgenic animal platforms including a superior antibody response with greater antibody diversity. OmniRat shortens development time required to humanize antibodies obtained using non-transgenic animals. Antibody Solutions is a privately held antibody technology and services company based in Sunnyvale CA. Open Monoclonal Technology, Inc. (OMT) is a leader in genetic engineering of animals for creation of human therapeutic antibodies, naturally optimized human antibodies, and the only company in the world with three transgenic animal platforms, OmniAb™.